CAR-T Intraperitoneal Infusions for CEA-Expressing Adenocarcinoma Peritoneal Metastases or Malignant Ascites (IPC)
Status: WITHDRAWN
Study type: INTERVENTIONAL
Conditions: Peritoneal Carcinomatosis|Peritoneal Metastases|Colorectal Cancer|Gastric Cancer|Breast Cancer|Pancreas Cancer|Carcinoembryonic Antigen
Interventions: BIOLOGICAL: anti-CEA CAR-T cells
Sponsor: Sorrento Therapeutics, Inc.